RT Journal Article SR Electronic T1 Postmarketing adverse drug reactions JF Neurology: Clinical Practice FD Lippincott Williams & Wilkins SP 288 OP 294 DO 10.1212/CPJ.0b013e3182a1b9f0 VO 3 IS 4 A1 Klein, Eran A1 Bourdette, Dennis YR 2013 UL http://cp.neurology.org/content/3/4/288.abstract AB Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.